BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
Public ClinicalTrials.gov record NCT00459667. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
International, Multicenter, Phase IIIb Study of Subcutaneous Every-other-day Treatment of Patients With Relapsing Multiple Sclerosis With (Phase A): Double-blind Betaseron/Betaferon 250µg or 500µg or Open-label Betaseron/Betaferon 250µg and (Phase B): Open-label Betaseron/Betaferon 500µg
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The BEYOND Follow-Up study will give patients who participated in the preceding BEYOND study the opportunity to continue treatment with the 500µg dose of interferon beta (IFNB) 1b and will further investigate the safety and tolerability profile of interferon beta 1b 500µg during longer-term treatment.
Study identification
- NCT ID
- NCT00459667
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,420 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Mar 2008 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- Apr 23, 2015
2007 – 2008
United States locations
- U.S. sites
- 51
- U.S. states
- 32
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294-7340 | — |
| Not listed | Cullman | Alabama | 35058 | — |
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Tucson | Arizona | 85741 | — |
| Not listed | Berkeley | California | 94705 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | San Francisco | California | 94117 | — |
| Not listed | Fort Collins | Colorado | 80528 | — |
| Not listed | Newark | Delaware | 19713 | — |
| Not listed | Washington D.C. | District of Columbia | 20037 | — |
| Not listed | Maitland | Florida | 32751 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | Atlanta | Georgia | 30309-1465 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Fort Wayne | Indiana | 46805 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Des Moines | Iowa | 50314 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Shreveport | Louisiana | 71130 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Henderson | Nevada | 89052 | — |
| Not listed | Reno | Nevada | 89509 | — |
| Not listed | Newark | New Jersey | 07103 | — |
| Not listed | Albuquerque | New Mexico | 87131-5281 | — |
| Not listed | Mineola | New York | 11501 | — |
| Not listed | Rochester | New York | 14642 | — |
| Not listed | Stony Brook | New York | 11794 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Tualatin | Oregon | 97062 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Providence | Rhode Island | 02905 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Nashville | Tennessee | 37205 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Fairfax | Virginia | 22031 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Tacoma | Washington | 98405 | — |
| Not listed | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00459667, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2015 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00459667 live on ClinicalTrials.gov.